In a recent Perspective by William J. Waddell, "Thresholds in Chemical Carcinogenesis: What are Animal Experiments Telling Us?," Toxicol. Pathol. 31: 260-262, 2003 , a procedure is presented that claims to unequivocally provide high dose estimates of threshold doses for carcinogens. It is claimed that it is possible to establish a threshold dose, below which no tumors will be induced, by establishing the line for the excess tumor incidence above the background incidence as a function of the logarithm of the dose expressed as molecules/kg body weight/day. Where this line intersects the dose axis is claimed to provide the threshold dose. Lowdose and high-dose data points that do not visually fall near a line are conveniently discarded. With this process, the center portion of any sigmoidal dose response curve, which may or may not have a true threshold dose, can be approximated by a line. Extrapolating this line segment to the dose axis creates a "false" threshold that may not be near a true threshold, if one exists.
Using the extrapolation procedure described above, a threshold dose of 10 19.4 molecules/kg/day of 2-acetylaminofluorene in mice is claimed for bladder tumors at 33 months. Examination of the data shows that among mice sacrificed at 33 months none of the controls had bladder tumors and 9.1% of the mice had bladder tumors that were exposed at 60 ppm in the diet, ie, at the threshold dose of 10 19.4 molecules/kg/day. Obviously, the Waddell extrapolation procedure did not provide a threshold dose.
A simple mathematical example, where we can examine the true situation without experimental error, will serve to illustrate the fallacy of the Waddell extrapolation procedure. Suppose the true dose response for the excess proportion (P) of animals with tumors is the following simple linear function of dose through zero without a threshold P = 0.2 × 10 −20 × dose.
At doses of 1 × 10 20 , 2 × 10 20 , and 3 × 10 20 , the true proportions of animals with tumors are: 0.2, 0.4, and 0.6, respectively. Fitting a dose response line to these data of the form P versus log(dose) gives P = −16.2086 + 0.8198 × log(dose) with a correlation coefficient of 0.98875. This extremely high correlation only indicates that the fitted line of P versus the log(dose) provides a good approximation in the dose range of 1 × 10 20 through 3 × 10 20 . The high correlation does not prove that P versus the log(dose) is linear, in fact, we know that the correct model in this case is a linear function of P versus dose. Further, extrapolation of the Waddell model to the dose axis gives a threshold dose of 5.9 × 10 19 molecules/kg/day, when in fact there is no threshold dose. Actually, the true tumor incidence at the extrapolated threshold is 11.8%.
Obviously, expressing dose as molecules/kg/day rather than mg/kg/day makes no difference mathematically. One dose metric is simply a multiple of the other. Expressing dose on a molecule basis does remind us that these experimental doses generally are relatively high. There is nothing inherently wrong with plotting dose on a log scale if this helps to simplify the mathematics or understand the biology. However, squeezing the plot into 1/4th inch of the dose scale makes it virtually impossible to visually detect any curvature.
I certainly do not deny that threshold doses may exist for carcinogens as a result of detoxification through repair, metabolism, pharmacokinetics, etc. Thresholds may be supported by an understanding of the mechanism of action, but not by plotting and curve fitting to relatively crude tumor incidence data that, eg, only occur in increments of 2% with 50 animals per dose group. Even if there were no tumors observed in 1000 dosed animals, we can only be 95% confident that the true tumor incidence at this dose is less than 3 in 1000.
The several publications on extrapolation of linear plots of tumor incidence versus log(dose) that claim to produce threshold doses do provide an extremely important result that should concern all of us. These papers demonstrate a repeated failure of the peer review system for an important quantitative issue in biology.
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